Alizapride (BioDeep_00000015199)

Main id: BioDeep_00000033333

 


代谢物信息卡片


6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1,2,3-benzotriazole-5-carboxamide

化学式: C16H21N5O2 (315.1695166)
中文名称: 阿立必利
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C=CCN1CCCC1CNC(=O)c1cc2c(cc1OC)n[nH]n2
InChI: InChI=1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20)

描述信息

D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
D005765 - Gastrointestinal Agents > D000932 - Antiemetics
D002491 - Central Nervous System Agents

同义名列表

3 个代谢物同义名

Alizapride; 6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1,2,3-benzotriazole-5-carboxamide; Alizaprida [inn-spanish];Alizapridum [inn-latin]



数据库引用编号

9 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • R Scott Obach, Franco Lombardo, Nigel J Waters. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals. 2008 Jul; 36(7):1385-405. doi: 10.1124/dmd.108.020479. [PMID: 18426954]
  • E Rey, E Stettler, P D'athis, G Pons. Pharmacokinetics of alizapride in children receiving chemotherapy for solid tumour. Fundamental & clinical pharmacology. 2001 Jun; 15(3):217-20. doi: 10.1046/j.1472-8206.2001.00022.x. [PMID: 11468033]
  • B Neri, S Bartalucci, P Rizzo, G Nicita, R Ponchietti. Control of nephrotoxicity by hydration-diuresis, and of emesis by alizapride, during cisplatin administration in patients with bladder cancer. Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques. 1988 Nov; 10(5):389-92. doi: NULL. [PMID: 3079128]
  • A P de Jong, A J Wittebrood, W M du Châtinier, J Bron. Liquid chromatographic analysis of alizapride and metoclopramide in human plasma and urine using solid-phase extraction. Journal of chromatography. 1987 Aug; 419(?):233-42. doi: 10.1016/0378-4347(87)80281-5. [PMID: 3667781]
  • P Canal, H Roche, M Pasquier, R Bugat, D Berg, G Soula, M Carton. Pharmacokinetics of high-dose i.v. alizapride in prevention of cisplatin-induced emesis. Fundamental & clinical pharmacology. 1987; 1(3):213-7. doi: 10.1111/j.1472-8206.1987.tb00559.x. [PMID: 3428840]
  • Y Coulais, G Campistron, C Caillard, G Houin. Quantitative determination of alizapride in human plasma by high-performance liquid chromatography. Journal of chromatography. 1986 Jan; 374(2):425-9. doi: 10.1016/s0378-4347(00)83304-6. [PMID: 3958102]
  • H Hoffmann, S Jacobi. [Hydrolysis of the antiemetic alizapride]. Arzneimittel-Forschung. 1984; 34(12):1714-5. doi: NULL. [PMID: 6543307]
  • B Metivier, A Servin, H Renault, C Jacquot. Pharmacokinetic study of digoxin-benzamide interaction in the rat. International journal of nuclear medicine and biology. 1984; 11(1):103-5. doi: 10.1016/0047-0740(84)90043-3. [PMID: 6735603]
  • G Houin, F Bree, N Lerumeur, J P Tillement. High-performance liquid chromatographic determination of alizapride, a new antiemetic compound, and its application to a dose-dependent pharmacokinetic study. Journal of pharmaceutical sciences. 1983 Jan; 72(1):71-4. doi: 10.1002/jps.2600720117. [PMID: 6827466]